DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES

树突状细胞和 T 细胞在抗细菌 lg 反应中的作用

基本信息

项目摘要

Streptococcus pneumoniae (Pn)is an extracellular bacterium that is a major cause of global morbidity and mortality. Systemic adaptive immunity to Pn is mediated by antibody, especially IgG specific for the capsular polysaccharide (PS),but also for bacterial proteins. Our long-term goal is to elucidate the cellular mechanismsthat underlie the distinct differences that exist between in vivo anti-PSand anti-protein Ig responses to intact Pn, as a prerequisite to the development of improved vaccines.In contrast to the current dogma, based on using purified PS antigens, that IgG anti-PS responses are T cell-independent, we demonstrated that the IgG anti-PS response to intact Pn is heavily dependent on CD4+ T cells but nevertheless, still exhibits striking differences in kinetics, generation of memory, and the functional roles of dendritic and T cells relative to the co-induced anti-protein response. In light of these data, the central hypothesis that underlies our proposed research is that differential B cell receptor signaling and/or involvement of functionally distinct B cell subsets are the key parametersthat distinguish physiologic anti-PS and anti-protein Ig responses. We will demonstrate that these parameters differentially impact on 1) the temporal compartmentalization of responding B cells within the spleen, and 2) the cellular interactions of the responding B cells with other immune cell types. As a result we will provide a mechanistic basis that will elucidate the observed differences in anti-PS and anti-protein responses. The specific aims are to: 1. Determine the nature and relationships of B cell and dendritic cell subsets, and CD4+ T cells that differentially mediate in vivo anti-PS and anti-protein Ig isotype responses to systemic immunization with intact Pn. We will utilize high speed electronic cell sorting and adoptive transfer of wild-type and genetically altered immune cells combined with ELISPOT and ELISA analyses of antigen-specific Ig isotype production to accomplish thisaim. 2. Determine the mechanism by which B cells, DCs,and CD4+ T cells differentially orchestrate anti-PS and anti-protein responses within a spatiotemporal context. We will utilize B cells from BCR knock-in mice with Ig specificity for Pn-derived PS or protein antigens and T cells from CD4+ TCR transgenic mice with specificity for a Pn-derived protein to accomplish this aim.These cells will be used to conduct in vitro functional studies and confocal microscopic analyses of splenic tissue sections post-immunization. These studies are the first to systematically determine the mechanisms that distinguish anti-PS from anti-protein responses to an intact bacterium and provide novel basic immunologic insights with direct relevanceto the development of anti-bacterial vaccines.
肺炎链球菌(Pn)是一种胞外细菌,是全球发病的主要原因 and mortality.对Pn的系统适应性免疫是由抗体介导的,特别是对Pn特异的IgG。 荚膜多糖(PS),但也用于细菌蛋白质。我们的长期目标是阐明 体内抗PS和抗PS之间存在明显差异的细胞机制 抗蛋白质IG应答完整的Pn,作为开发改进疫苗的先决条件。 与目前基于使用纯化PS抗原的教条相反,IgG抗PS应答是T 不依赖于细胞,我们证明了IgG抗PS对完整Pn的反应在很大程度上依赖于CD 4 + 尽管如此,T细胞在动力学、记忆的产生和免疫功能方面仍然表现出惊人的差异。 树突状细胞和T细胞相对于共同诱导的抗蛋白应答的功能作用。鉴于这些 数据,我们提出的研究基础的中心假设是,差异B细胞受体 功能不同的B细胞亚群的信号传导和/或参与是 区分生理性抗PS和抗蛋白质IG应答。我们将证明,这些 参数差异性地影响:1)响应性B细胞在细胞内的时间区室化, 脾,和2)应答B细胞与其它免疫细胞类型的细胞相互作用。结果我们 将提供一个机制的基础,将阐明所观察到的差异,抗PS和抗蛋白 应答具体目标是: 1.确定B细胞和树突状细胞亚群以及CD 4 + T细胞的性质和关系, 差异介导体内抗PS和抗蛋白质IG同种型对全身免疫的应答 完整的Pn。我们将利用高速电子细胞分选和野生型和非野生型细胞的过继转移。 结合ELISPOT和抗原特异性IG同种型的ELISA分析的遗传改变的免疫细胞 生产,以实现这一目标。 2.确定B细胞、DC和CD 4 + T细胞差异协调的机制 抗PS和抗蛋白质反应的时空背景下。我们将利用来自BCR的B细胞 对Pn衍生的PS或蛋白抗原和来自CD 4 + TCR的T细胞具有IG特异性的敲入小鼠 这些细胞将被用于 进行脾组织切片的体外功能研究和共聚焦显微镜分析 免疫后。这些研究首次系统地确定了 区分抗PS与抗蛋白质反应的完整细菌,并提供新的基础 immunologic免疫insights见解with direct直接relevance相关to the development发展of anti-bacterial抗bacterial细菌vaccines疫苗.

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pneumococcal Surface Protein A Plays a Major Role in Streptococcus pneumoniae-Induced Immunosuppression.
  • DOI:
    10.4049/jimmunol.1502709
  • 发表时间:
    2016-05-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saumyaa;Pujanauski L;Colino J;Flora M;Torres RM;Tuomanen E;Snapper CM
  • 通讯作者:
    Snapper CM
A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
CpG 寡脱氧核苷酸的关键 DNA 侧翼序列(但不是 6 碱基 CpG 基序)可以用 RNA 替换,而不会导致 Toll 样受体 9 介导的活性发生量或质的变化。
  • DOI:
    10.1016/j.cellimm.2005.01.010
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sen,Goutam;Flora,Michael;Chattopadhyay,Gouri;Klinman,DennisM;Lees,Andrew;Mond,JamesJ;Snapper,CliffordM
  • 通讯作者:
    Snapper,CliffordM
Distinct Immunologic Properties of Soluble Versus Particulate Antigens.
  • DOI:
    10.3389/fimmu.2018.00598
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Snapper CM
  • 通讯作者:
    Snapper CM
Macrophages pulsed with Streptococcus pneumoniae elicit a T cell-dependent antibody response upon transfer into naive mice.
用肺炎链球菌脉冲的巨噬细胞在转移到初始小鼠体内后会引发 T 细胞依赖性抗体反应。
  • DOI:
    10.4049/jimmunol.181.3.1787
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Vasilevsky,Sam;Colino,Jesus;Puliaev,Roman;Canaday,DavidH;Snapper,CliffordM
  • 通讯作者:
    Snapper,CliffordM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLIFFORD M SNAPPER其他文献

CLIFFORD M SNAPPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLIFFORD M SNAPPER', 18)}}的其他基金

(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
基于(聚)甘油磷酸盐的交叉保护性抗葡萄球菌疫苗
  • 批准号:
    8074028
  • 财政年份:
    2010
  • 资助金额:
    $ 32.15万
  • 项目类别:
(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
基于(聚)甘油磷酸盐的交叉保护性抗葡萄球菌疫苗
  • 批准号:
    7963436
  • 财政年份:
    2010
  • 资助金额:
    $ 32.15万
  • 项目类别:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
GP350 作为新型疫苗蛋白载体
  • 批准号:
    7958394
  • 财政年份:
    2009
  • 资助金额:
    $ 32.15万
  • 项目类别:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
GP350 作为新型疫苗蛋白载体
  • 批准号:
    7562069
  • 财政年份:
    2007
  • 资助金额:
    $ 32.15万
  • 项目类别:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
多糖缀合物和 EBV 疫苗的新型载体
  • 批准号:
    7537173
  • 财政年份:
    2007
  • 资助金额:
    $ 32.15万
  • 项目类别:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
多糖缀合物和 EBV 疫苗的新型载体
  • 批准号:
    7388052
  • 财政年份:
    2007
  • 资助金额:
    $ 32.15万
  • 项目类别:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
GP350 作为新型疫苗蛋白载体
  • 批准号:
    7349607
  • 财政年份:
    2006
  • 资助金额:
    $ 32.15万
  • 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
树突状细胞和 T 细胞在抗细菌 lg 反应中的作用
  • 批准号:
    7219524
  • 财政年份:
    2001
  • 资助金额:
    $ 32.15万
  • 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
树突状细胞和 T 细胞在抗菌 Ig 反应中的作用
  • 批准号:
    6317430
  • 财政年份:
    2001
  • 资助金额:
    $ 32.15万
  • 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
树突状细胞和 T 细胞在抗菌 Ig 反应中的作用
  • 批准号:
    6870301
  • 财政年份:
    2001
  • 资助金额:
    $ 32.15万
  • 项目类别:

相似海外基金

New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
  • 批准号:
    1654774
  • 财政年份:
    2015
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8416313
  • 财政年份:
    2012
  • 资助金额:
    $ 32.15万
  • 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8298885
  • 财政年份:
    2012
  • 资助金额:
    $ 32.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了